ANTINUCLEAR ANTIBODIES IN PATIENTS TAKING L1

[1] SEVERE CARDIOVASCULAR ADVERSE-EFFECTS IN ASSOCIATION WITH ACUTE, HIGH-DOSE CORTICOSTEROID ADMINISTRATION [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (12): : 1019 - 1023

[2] SUDDEN-DEATH AFTER TREATMENT WITH PULSED METHYLPREDNISOLONE [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6717) : 125 - 125

[3] LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 295 - 300

[4] MEHTA, 1991, LANCET, V337, P298

[5] COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS [J]. LANCET, 1990, 336 (8726) : 1275 - 1279

[6] Porter J B, 1989, Baillieres Clin Haematol, V2, P459, DOI 10.1016/S0950-3536(89)80027-7

[7] TONDURY P, 1990, BRIT J HAEMATOL, V76, P550

[8] PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) : 1600 - 1603

[1] SEVERE CARDIOVASCULAR ADVERSE-EFFECTS IN ASSOCIATION WITH ACUTE, HIGH-DOSE CORTICOSTEROID ADMINISTRATION [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (12): : 1019 - 1023

[2] SUDDEN-DEATH AFTER TREATMENT WITH PULSED METHYLPREDNISOLONE [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6717) : 125 - 125

[3] LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 295 - 300

[4] MEHTA, 1991, LANCET, V337, P298

[5] COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS [J]. LANCET, 1990, 336 (8726) : 1275 - 1279

[6] Porter J B, 1989, Baillieres Clin Haematol, V2, P459, DOI 10.1016/S0950-3536(89)80027-7

[7] TONDURY P, 1990, BRIT J HAEMATOL, V76, P550

[8] PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) : 1600 - 1603